PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine 3 (Nephrology and Dialysis), Feldkirch Academic Teaching Hospital, Feldkirch, Austria.\', \'Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria.\', \'Agency for Preventive and Social Medicine (aks), Bregenz, Austria.\', \'Department of Internal Medicine 1, Feldkirch Academic Teaching Hospital, Feldkirch, Austria.\', \'Department of Medical Statistics, Informatics and Health Economics, Innsbruck Medical University, Innsbruck, Austria.\', \'Department of Internal Medicine 2, Feldkirch Academic Teaching Hospital, Feldkirch, Austria.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2021.704773
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34220867
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
?:title
  • The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients.
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34220867>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34220867>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all